1. LL-202, a newly synthesized flavonoid, inhibits tumor growth via inducing G2/M phase arrest and cell apoptosis in MCF-7 human breast cancer cells in vitro and in vivo
   Lei Tao et al, 2014, Toxicology Letters CrossRef
2. Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy
   Tapan Mahendra Kadia et al, 2019, Oncotarget CrossRef
3. Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol
   BURAK CEM SONER et al, 2014, International Journal of Molecular Medicine CrossRef
4. Nutraceutical Compounds as Sensitizers for Cancer Treatment in Radiation Therapy
   Marco Calvaruso et al, 2019, International Journal of Molecular Sciences CrossRef
5. Flavopiridol: a promising cyclin-dependent kinase inhibitor in cancer treatment
   Uttam Singh Baghel et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef